Aurobindo Pharma commissions four plants in Andhra Pradesh including Pen-G facility

The Rs 2,400 crore Pen-G plant is expected to start trial production in April and commercial production in a couple of months and the ramping up of the production will happen during the second quarter of the current fiscal, a senior official of the city-based drug maker had earlier said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/RTFyfl9
via IFTTT